Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.59 |
| ▸ | LPAR3 | Q9UBY5 | 7/20 | 0.47 |
| ▸ | LPAR2 | Q9HBW0 | 5/20 | 0.47 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | ESR1 | P03372 | 1/20 | 0.39 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.39 |
| ▸ | CDC25A | P30304 | 1/20 | 0.39 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.39 |
| ▸ | AKT1 | P31749 | 1/20 | 0.39 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.39 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17923932 | 1.00 | CYP3A4 (0.59) | CYP3A4LPAR3LPAR2LPAR1TSHR | |
| SCHEMBL11284626 | 0.98 | CYP3A4 (0.57) | CYP3A4LPAR3LPAR2LPAR1TSHR | |
| SCHEMBL11209051 | 0.94 | CYP3A4 (0.68) | CYP3A4LPAR3LPAR2LPAR1TSHR | |
| SCHEMBL11318577 | 0.94 | CYP3A4 (0.68) | CYP3A4LPAR3LPAR2LPAR1TSHR | |
| SCHEMBL11312474 | 0.86 | CYP3A4 (0.48) | CYP3A4TSHR | |
| SCHEMBL11207515 | 0.86 | CYP3A4 (0.48) | CYP3A4TSHR | |
| SCHEMBL56777 | 0.83 | CYP3A4 (0.84) | CYP3A4LPAR3LPAR2LPAR1TSHR | |
| SCHEMBL25569020 | 0.81 | CYP3A4 (0.45) | CYP3A4TSHR | |
| SCHEMBL258318 | 0.81 | CYP3A4 (0.80) | CYP3A4LPAR3LPAR2LPAR1TSHR | |
| SCHEMBL21440331 | 0.81 | CYP3A4 (0.80) | CYP3A4LPAR3LPAR2LPAR1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4071849-B1 | NONAQUEOUS ELECTROLYTE SECONDARY BATTERY | PANASONIC ENERGY CO LTD (JP) | 2024-04-17 | — | — | EP | disclosed |
| US-20230028128-A1 | NONAQUEOUS ELECTROLYTE SECONDARY BATTERY | SANYO ELECTRIC CO., LTD. (JP) | 2023-01-26 | — | — | US | disclosed |
| US-20220238909-A1 | SECONDARY LITHIUM-ION BATTERY ELECTROLYTE SOLUTION FOR REDUCING BATTERY RESISTANCE AND SECONDARY LITHIUM-ION BATTERY THEREOF | GUANGZHOU TINCI MATERIALS TECHNOLOGY CO., LTD. (CN) | 2022-07-28 | — | — | US | disclosed |
| CN-114762166-A | Non-aqueous electrolyte secondary battery | 三洋电机株式会社 | 2022-07-15 | — | — | CN | disclosed |
| EP-3972024-A1 | SECONDARY LITHIUM-ION BATTERY ELECTROLYTE FOR REDUCING BATTERY RESISTANCE AND SECONDARY LITHIUM-ION BATTERY THEREOF | Guangzhou Tinci Materials Technology Co., Ltd. (CN) | 2022-03-23 | — | — | EP | disclosed |
| CN-110212235-A | A kind of lithium secondary cell electrolyte and its lithium secondary battery reducing battery impedance | 广州天赐高新材料股份有限公司 | 2019-09-06 | — | — | CN | disclosed |
| EP-2683011-B1 | NONAQUEOUS ELECTROLYTE SOLUTION FOR BATTERIES, AND NONAQUEOUS ELECTROLYTE SECONDARY BATTERY USING SAME | DENSO CORP (JP) | 2018-02-28 | — | — | EP | disclosed |
| EP-2613395-B1 | NONAQUEOUS ELECTROLYTE SECONDARY BATTERY | ADEKA CORP (JP) | 2018-02-07 | — | — | EP | disclosed |
| US-20160190644-A1 | RECHARGEABLE LITHIUM BATTERY | SAMSUNG SDI CO., LTD. (KR) | 2016-06-30 | — | — | US | disclosed |
| EP-3038194-A1 | RECHARGEABLE LITHIUM BATTERY | Samsung SDI Co., Ltd. (KR) | 2016-06-29 | — | — | EP | disclosed |
| US-9379411-B2 | Non-aqueous electrolyte secondary battery | ADEKA CORPORATION (JP) | 2016-06-28 | — | — | US | disclosed |
| EP-2613395-A1 | NONAQUEOUS ELECTROLYTE SECONDARY BATTERY | Adeka Corporation (JP) | 2013-07-10 | — | — | EP | disclosed |
| US-20130149603-A1 | NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY | ADEKA CORPORATION (JP) | 2013-06-13 | — | — | US | disclosed |
| EP-0000127-B1 | INSECTICIDAL AND ACARICIDAL COMPOSITIONS, THEIR MANUFACTURE AND THEIR USE | BAYER AG (DE) | 1982-10-20 | — | — | EP | disclosed |
| US-4257987-A | SYNERGISTIC ARTHROPODICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 1981-03-24 | — | — | US | disclosed |
| EP-0012452-A2 | Phosphoric acid esters and their use in pesticidal compositions | BAYER AG (DE) | 1980-06-25 | — | — | EP | disclosed |
| EP-0000127-A1 | Insecticidal and acaricidal compositions, their manufacture and their use | BAYER AG (DE) | 1979-01-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230028128-A1 | NONAQUEOUS ELECTROLYTE SECONDARY BATTERY | VDAC2, NEK6, VDAC1 | CYP3A4 4424/4885LPAR3 4623/4885LPAR2 4210/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.